Business / Finance

RSS

PLSG reaches significant landmark in direct investments into life sciences companies

Pittsburgh Life Sciences Greenhouse, the region's only pure life sciences investment firm, and managing member of the PLSG Accelerator Fund, announced today it has made a $65,000 investment into Cohera Medical, Inc. which launches the organization into a $20 million milestone in total investments since the company's inception in 2001.

21 Jan 2014

Par Pharmaceutical enters into definitive agreement to purchase JHP Group Holdings

Par Pharmaceutical Companies, Inc. today announced that it has entered into a definitive agreement to acquire JHP Group Holdings, the parent company of JHP Pharmaceuticals, a leading specialty pharmaceutical company that develops, manufactures and markets branded and generic sterile injectable products.

21 Jan 2014

Watercrest Senior Living Group finalizes $500M co-development partnership

Watercrest Senior Living Group of Vero Beach, FL, and Index International AB, headquartered in Stockholm, Sweden, announce the finalization of their $500 million partnership in the co-development of senior living communities in the United States.

21 Jan 2014

Illumina inks multi-year supply agreement with LabCorp

Illumina, Inc. today announced it has entered into a multi-year supply agreement with Laboratory Corporation of America Holdings. The agreement gives LabCorp expanded rights to use Illumina next-generation sequencing and microarray equipment and supplies to develop, validate and introduce laboratory-developed tests to clinicians in the United States and Canada.

From Illumina, Inc. 21 Jan 2014

Synthelis secures initial funding to accelerate commercial development of membrane proteins

Synthelis, a company specializing in the production and characterization of therapeutic targets and antigens, announces today that it has secured initial backing of EUR 610,000 from a group of French investors comprising Rhone-Alpes Creation, Alpes Developpement Durable Investissement (A2D-Invest), Sud Rhone-Alpes Capital, Viaduc and the Savoy and Grenoble Business Angels networks.

21 Jan 2014

Virginia Mason and Vera Whole Health announce strategic collaboration

Virginia Mason and Vera Whole Health today announced a strategic collaboration that brings Virginia Mason's clinical best practices to Vera Whole Health's employer-funded primary care clinics.

21 Jan 2014

H.I.G. Capital sells MagnaCare Holdings to investor group

H.I.G. Capital, LLC, a leading global private equity investment firm with more than $13 billion of equity capital under management, announced today that it has completed the sale of its portfolio company MagnaCare Holdings, Inc. to an investor group led by an affiliate of Goldman Sachs, Pamplona Capital Management, and the MagnaCare Management Team.

20 Jan 2014

RBCC's partner Nano3D Biosciences develops new 3D bioprinting system

Rainbow Coral Corp. is well-positioned to capitalize on the revolution in medicine being spurred on by 3D printing technology thanks to the innovative BiO Assay, a new 3D bioprinting system developed by RBCC's joint venture partner, Nano3D Biosciences (n3D).

20 Jan 2014

Prostate cancer vaccines receive a boost in funding

The development of two innovative new vaccines that are hoped to offer an alternative to castration therapy for men with recurring prostate cancer, is due for an $8 million boost in funding.

16 Jan 2014

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Aqua Pharmaceuticals Holdings, Inc. to Almirall S.A. for up to $402.6 million in cash

16 Jan 2014

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.

16 Jan 2014

TaiGen, R-Pharm sign exclusive agreement to develop and commercialize nemonoxacin

TaiGen Biotechnology Company, Limited today announced that they have signed an exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn) in the Russian Federation, Turkey and other members of the Commonwealth Independent States.

15 Jan 2014

Nineteen new CDTs to be announced by Universities and Science Minister

Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy will receive a boost today. Nineteen new Centres for Doctoral Training (CDTs) will be announced by Universities and Science Minister, David Willetts.

10 Jan 2014

IBM and OhioHealth collaborate to aid in prevention of infections in hospitals

OhioHealth and IBM today announced a collaboration to aid in the prevention of infections using a first-of-a-kind network of wireless sensors and real-time Big Data analytics that measure hand-washing practices.

10 Jan 2014

Life Technologies, Quest Diagnostics sign multi-year license and supply agreement

Life Technologies has completed a multi-year license and supply agreement with Quest Diagnostics, the world's leading provider of diagnostic information services, that gives Quest rights to develop molecular tests on the Ion Torrent next-generation sequencing platform. Under the agreement, Quest may use the platform and related consumables to independently develop new tests for numerous areas of their business.

From Quest Diagnostics 10 Jan 2014

NAMSA announces acquisition of Medvance

NAMSA, the world's leading medical research organization, is pleased to announce the acquisition of Medvance Ltd., a clinical research and resourcing organization located in Yorkshire, England.

10 Jan 2014

Akorn acquires NDA and all rights to Betimol from Santen

Akorn, Inc., a niche generic pharmaceutical company, today announced that it has acquired the NDA and all rights to Betimol (timolol ophthalmic solution) 0.25% & 0.5% from Santen. Akorn plans to begin shipping Betimol in the first quarter of 2014.

9 Jan 2014

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Biogen Idec and Sangamo BioSciences, Inc. announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that result from the abnormal structure or underproduction of hemoglobin.

9 Jan 2014

Zymeworks, ImClone Systems partner to develop novel bi-specific antibody oncology therapeutics

Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody oncology therapeutics using Zymeworks' proprietary Azymetric platform. Bi-specific antibodies have the potential to provide improved outcomes for patients by simultaneously targeting two tumor associated antigens to induce a synergistic therapeutic response.

9 Jan 2014

Illumina signs multi-year licensing agreement with Quest Diagnostics

Illumina, Inc. today announced it has entered into a multi-year licensing agreement with Quest Diagnostics, the world's leading provider of diagnostic information services, related to the use of Illumina's next-generation sequencing technology for clinical laboratory testing.

From Illumina, Inc. 9 Jan 2014

Business / Finance

PLSG reaches significant landmark in direct investments into life sciences companies

Par Pharmaceutical enters into definitive agreement to purchase JHP Group Holdings

Watercrest Senior Living Group finalizes $500M co-development partnership

Illumina inks multi-year supply agreement with LabCorp

Synthelis secures initial funding to accelerate commercial development of membrane proteins

Virginia Mason and Vera Whole Health announce strategic collaboration

H.I.G. Capital sells MagnaCare Holdings to investor group

RBCC's partner Nano3D Biosciences develops new 3D bioprinting system

Prostate cancer vaccines receive a boost in funding

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

TaiGen, R-Pharm sign exclusive agreement to develop and commercialize nemonoxacin

Nineteen new CDTs to be announced by Universities and Science Minister

IBM and OhioHealth collaborate to aid in prevention of infections in hospitals

Life Technologies, Quest Diagnostics sign multi-year license and supply agreement

NAMSA announces acquisition of Medvance

Akorn acquires NDA and all rights to Betimol from Santen

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Zymeworks, ImClone Systems partner to develop novel bi-specific antibody oncology therapeutics

Illumina signs multi-year licensing agreement with Quest Diagnostics

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News